DF
IONS icon

Dunhill Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Dunhill Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201 Sell
2
-1
-33% -$79 ﹤0.01% 1252
2025
Q4 		$212 Buy
+3
New +$226 ﹤0.01% 1099
2024
Q4 		– Sell
-130
Closed -$5.21K – 944
2024
Q3 		$5.21K Hold
130
– – ﹤0.01% 539
2024
Q2 		$6.2K Buy
+130
New +$5.33K ﹤0.01% 368

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dunhill Financial's IONS Position: Q1 2026 in Review

Dunhill Financial reduced its Ionis Pharmaceuticals (IONS) stake by 33% in Q1 2026, selling an estimated $79 and leaving 2 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Dunhill Financial first reported a position in IONS in Q2 2024 and has held it in 4 quarters since. The position peaked at $6.2K in Q2 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Dunhill Financial held 2 shares of Ionis Pharmaceuticals worth $201 as of Q1 2026.
  • Dunhill Financial sold 1 Ionis Pharmaceuticals share in Q1 2026, an estimated $79.
  • Ionis Pharmaceuticals made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1252 holding.
  • Dunhill Financial first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Dunhill Financial's Ionis Pharmaceuticals position peaked at $6.2K in Q2 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.